Menopause Health Center
Premature Ovarian Failure - Topic Overview
Is this topic for you?
This topic contains information about loss of ovarian function before age 40. If you want information about the normal loss of ovarian function around age 50 or about symptoms in the few years before it, see the topic Menopause and Perimenopause.
What is premature ovarian failure?
Premature ovarian failure occurs when your ovaries-which store and release eggs-stop working before age 40. You may have no or few eggs. Depending on the cause, premature ovarian failure may develop as early as the teen years, or the problem may have been present from birth.
A woman who has premature ovarian failure is very likely to have irregular or no periods, infertility problems, and menopause-like symptoms. It is difficult, though not impossible, for women who have premature ovarian failure to become pregnant.
What causes premature ovarian failure?
Although the exact cause of premature ovarian failure may be unknown, a genetic factor or a problem with the body's immune system may play a role in some women. In an immune system disorder, the body may attack its own tissues-in this case, the ovaries.
Premature ovarian failure may develop after a hysterectomy or other pelvic surgery or from radiation or chemotherapy treatment for cancer. In some of these cases, the condition may be temporary, with the ovaries starting to work again some years later.
What are the symptoms?
The symptoms of premature ovarian failure are similar to those of menopause. Your menstrual periods may become irregular-you have a period one month but not the next-or they may stop. You also may have some or all of the symptoms of menopause, such as hot flashes, night sweats, irritability, vaginal dryness, low sex drive, or trouble sleeping.
How is premature ovarian failure diagnosed?
If your periods become irregular or stop, your doctor will give you a physical examination and ask you questions about your general health and whether you have other symptoms of premature ovarian failure. You will also have a pregnancy test, and your blood will be tested for other possible causes of irregular periods.
To check for possible ovarian failure, your blood level of follicle-stimulating hormone (FSH) will be checked. FSH signals your body to release an egg every month. If the amount of FSH in your blood is higher than normal on more than one day, you may have premature ovarian failure. Another blood test also may be done to measure the amount of estradiol (or estrogen) in your blood. Very low estrogen with a high FSH is a sign of premature ovarian failure.
Some women discover they have premature ovarian failure when they see a doctor because they are having trouble getting pregnant.
How is it treated?
Treatment for premature ovarian failure will help you manage your symptoms, but there is currently no treatment that will make the ovaries start to work properly again. Your doctor may prescribe hormone replacement therapy or other medicines to help with hot flashes. Hormone replacement therapy can also help prevent early bone loss in women who have premature ovarian failure. Talk to your doctors about which treatments may be right for you.
WebMD Medical Reference from Healthwise
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

